CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B
Lung-Yi Mak, Danny Wong, Alison Kuchta, Martina Hilfiker, Aaron Hamilton, Ning Chow, XianHua Mao, Wai Kay Seto, Man-Fung Yuen
Clin Mol Hepatol. 2023;29(1):146-162.   Published online 2022 August 19    DOI: https://doi.org/10.3350/cmh.2022.0172

Excel Download

Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B
Clinical and Molecular Hepatology. 2023;29(1):146-162   Crossref logo
Link1 Link2 Link3

Pregenomic HBV RNA and Hepatitis B Core‐Related Antigen Predict Outcomes in Hepatitis B e Antigen–Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue Therapy
Hepatology. 2020;72(1):42-57   Crossref logo
Link1 Link2 Link3 Link4

471 ON-TREATMENT SERUM HEPATITIS B SURFACE ANTIGEN LEVEL PREDICTS SUSTAINED VIROLOGICAL RESPONSE TO NUCLEOS(T)IDE ANALOGUE IN PATIENTS WITH HEPATITIS E ANTIGEN-POSITIVE CHRONIC HEPATITIS B
Journal of Hepatology. 2012;56:S186   Crossref logo
Link1 Link2

Very slow decline of hepatitis B virus surface antigen and core related antigen in chronic hepatitis B patients successfully treated with nucleos(t)ide analogues
Journal of Medical Virology. 2018;90(5):989-993   Crossref logo
Link1 Link2 Link3 Link4

Systematic review: cessation of long-term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen-negative chronic hepatitis B
Alimentary Pharmacology & Therapeutics. 2015;42(3):243-257   Crossref logo
Link1 Link2

Cumulative Incidence of Hepatocellular Carcinoma and Hepatitis B Surface Antigen Seroclearance after Nucleos(t)ide analogue-induced Hepatitis B e Antigen Seroclearance
. 2020;   Crossref logo
Link1 Link2

Cumulative Incidence of Hepatocellular Carcinoma and Hepatitis B Surface Antigen Seroclearance after Nucleos(t)ide analogue-induced Hepatitis B e Antigen Seroclearance
. 2019;   Crossref logo
Link1 Link2

Cumulative Incidence of Hepatocellular Carcinoma and Hepatitis B Surface Antigen Seroclearance after Nucleos(t)ide analogue-induced Hepatitis B e Antigen Seroclearance
. 2019;   Crossref logo
Link1 Link2

The Role of Hepatitis B Surface Antigen in Nucleos(t)ide Analogue Cessation Among Asian Chronic Hepatitis B Patients: Friend or Foe?
Hepatology. 2019;69(4):1843-1843   Crossref logo
Link1 Link2 Link3 Link4

Hepatitis B core-related antigen: a strong indicator for cessation of nucleos(t)ide analog therapy in patients with chronic hepatitis B
Journal of Gastroenterology. 2016;52(1):127-128   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.